Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Fokus Mining Intersects 10 Metres Grading 10.06 G/T At The Galloway Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arcturus Therapeutics Holdings Inc ARCT

Healthcare Biotechnology
Arcturus Therapeutics Holdings Inc. is a global messenger RNA medicines and vaccine company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid... see more

Recent & Breaking News (NDAQ:ARCT)

Ultragenyx Announces Exercise of Option to Purchase Additional Stock of Arcturus Therapeutics

GlobeNewswire May 21, 2020

Arcturus Reports Additional Supportive Preclinical Data for its COVID-19 Vaccine Candidate (LUNAR-COV19)

GlobeNewswire May 8, 2020

Arcturus Therapeutics Announces First Quarter 2020 Financial Results and Provides a Corporate Update

GlobeNewswire May 7, 2020

Arcturus Therapeutics to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 7, 2020

GlobeNewswire May 4, 2020

Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine

GlobeNewswire May 4, 2020

Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate

GlobeNewswire April 27, 2020

Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewswire April 21, 2020

Arcturus Therapeutics Announces Pricing of $70.0 Million Public Offering of Common Stock

GlobeNewswire April 16, 2020

Arcturus Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire April 15, 2020

Arcturus Therapeutics Announces Allowance of IND & Approval of Clinical Trial Application (CTA) for ARCT-810, a First-in-Class Investigational mRNA Medicine to Treat Ornithine Transcarbamylase Deficiency

GlobeNewswire April 13, 2020

Arcturus Therapeutics Announces Clinical Trial Timeline for its COVID-19 Vaccine

GlobeNewswire April 9, 2020

Arcturus COVID-19 Vaccine to Benefit from Duke-NUS Genetic Correlation System

GlobeNewswire March 27, 2020

Arcturus Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results

GlobeNewswire March 11, 2020

Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR Technology(TM)

GlobeNewswire March 4, 2020

Arcturus Therapeutics to Report Fourth Quarter and Year-End 2019 Financial Results and Provide Corporate Update on March 11

GlobeNewswire February 24, 2020

Arcturus Therapeutics to Present at Two Investor Conferences in March

GlobeNewswire February 19, 2020

Arcturus Therapeutics Appoints Steve Hughes, M.D., as Chief Development Officer

GlobeNewswire January 8, 2020

Arcturus Therapeutics to Present at the Investor Summit on December 17th in Philadelphia.

Accesswire December 11, 2019

Arcturus Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update

GlobeNewswire November 7, 2019

Arcturus Therapeutics Expands Platform with STARR Technology(TM)

GlobeNewswire November 7, 2019